These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4443026)

  • 1. Essential drugs committee views on drugs.
    Indian J Pediatr; 1974 May; 41(316):198-9. PubMed ID: 4443026
    [No Abstract]   [Full Text] [Related]  

  • 2. Keeping prescription drugs safe and effective.
    Bryan PA
    Am Fam Physician; 1974 Nov; 10(5):189-93. PubMed ID: 4421343
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA committee: More restrictions needed on hydrocodone combination products.
    Kuehn BM
    JAMA; 2013 Mar; 309(9):862. PubMed ID: 23462764
    [No Abstract]   [Full Text] [Related]  

  • 4. Statement on fixed ratio combinations of drugs.
    Moss JM
    Va Med Mon (1918); 1971 Sep; 98(9):472-3. PubMed ID: 5119159
    [No Abstract]   [Full Text] [Related]  

  • 5. American academy of pediatrics committee on drugs. Sulfonamide combinations: recent FDA action.
    Pediatrics; 1970 Sep; 46(3):473-4. PubMed ID: 5468780
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Regulating the introduction of new drugs.
    Lancet; 1974 Mar; 1(7856):490. PubMed ID: 4131888
    [No Abstract]   [Full Text] [Related]  

  • 7. Paregoric on prescription.
    Tice LF
    Am J Pharm Sci Support Public Health; 1972; 144(2):39-40. PubMed ID: 5068202
    [No Abstract]   [Full Text] [Related]  

  • 8. The downside of upscheduling.
    Gudin J; Lee AJ
    Pain Med; 2013 Nov; 14(11):1628-9. PubMed ID: 24238353
    [No Abstract]   [Full Text] [Related]  

  • 9. DEA reschedules hydrocodone combination products as schedule II.
    J Mich Dent Assoc; 2014 Oct; 96(10):11. PubMed ID: 25647867
    [No Abstract]   [Full Text] [Related]  

  • 10. Research, regulation and development of new pharmaceuticals: past, present and future. II.
    Lasagna L
    Am J Med Sci; 1972 Feb; 263(2):66-78. PubMed ID: 5017858
    [No Abstract]   [Full Text] [Related]  

  • 11. The development and introduction of new cardiovascular drugs. Seventh Bethesda Conference of the American College of Cardiology May 18-19, 1974, Washington, D.C. 3. Views of the food and drug Administration.
    Crout JR
    Am J Cardiol; 1974 Oct; 34(4):469-70. PubMed ID: 4153504
    [No Abstract]   [Full Text] [Related]  

  • 12. Better late than never: time to up-schedule hydrocodone combination products.
    Kolodny A
    Pain Med; 2013 Nov; 14(11):1627-8. PubMed ID: 24238352
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA panel recommends tighter rules for prescribing opioids.
    McCarthy M
    BMJ; 2013 Feb; 346():f1012. PubMed ID: 23412738
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA acts to limit exposure to acetaminophen in combination products.
    McCarthy M
    BMJ; 2014 Jan; 348():g356. PubMed ID: 24452448
    [No Abstract]   [Full Text] [Related]  

  • 15. From the Food and Drug Administration.
    Henney JE
    JAMA; 2000 Nov; 284(17):2178. PubMed ID: 11056574
    [No Abstract]   [Full Text] [Related]  

  • 16. America's drug problem.
    Philpott S
    Hastings Cent Rep; 2012; 42(4):9-10. PubMed ID: 22777971
    [No Abstract]   [Full Text] [Related]  

  • 17. The Committee and the pill.
    Diggory P
    Lancet; 1970 Jan; 1(7637):86. PubMed ID: 4188653
    [No Abstract]   [Full Text] [Related]  

  • 18. Toxicity of new drugs.
    Lowinger P
    Science; 1968 Aug; 161(3842):632. PubMed ID: 5664503
    [No Abstract]   [Full Text] [Related]  

  • 19. New drugs and new treatments.
    Walker E
    Mod Healthc (Short Term Care); 1975 Jul; 4(1):70B,70D. PubMed ID: 239322
    [No Abstract]   [Full Text] [Related]  

  • 20. Opening Pandora's box.
    Schwartz RH
    J Pediatr; 1977 Jul; 91(1):165-7. PubMed ID: 586260
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.